These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 35522824

  • 21. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Jing F, Weng H, Pei Q, Zhang J, Liu R, Yi Q.
    Clin Exp Med; 2022 Nov; 22(4):621-628. PubMed ID: 35039938
    [Abstract] [Full Text] [Related]

  • 22. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 23. Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.
    Kimura M, Harazaki M, Fukuoka T, Asakura I, Sakai H, Kamimaki T, Ohkawara I, Akiyama N, Tsurui S, Iwashima S, Shimomura M, Morishita H, Meguro T, Seto S.
    Pediatr Int; 2017 Apr; 59(4):397-403. PubMed ID: 27743415
    [Abstract] [Full Text] [Related]

  • 24. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases.
    Li X, Chen Y, Tang Y, Ding Y, Xu Q, Sun L, Qian W, Qian G, Qin L, Lv H.
    Eur J Pediatr; 2018 Aug; 177(8):1279-1292. PubMed ID: 29948255
    [Abstract] [Full Text] [Related]

  • 25. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
    Wu S, Liao Y, Sun Y, Zhang CY, Zhang QY, Yan H, Qi JG, Liu XQ, Chen YH, Wang YL, Li XY, Jin HF, Du JB.
    World J Pediatr; 2020 Dec; 16(6):607-613. PubMed ID: 32232677
    [Abstract] [Full Text] [Related]

  • 26. [Predictive value of serum ferritin and a new predictive model for intravenous immunoglobulin resistance in Kawasaki disease].
    Zhang YJ, Bai HT, Chen PL.
    Zhonghua Er Ke Za Zhi; 2021 Dec 02; 59(12):1080-1085. PubMed ID: 34856668
    [Abstract] [Full Text] [Related]

  • 27. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Dec 02; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 28. C-reactive protein to albumin ratio as a prognostic tool for predicting intravenous immunoglobulin resistance in children with kawasaki disease: a systematic review of cohort studies.
    Liu J, Chen X, Yang M, Shen F, Zhu F, Jin J, Teng Y.
    Pediatr Rheumatol Online J; 2024 Apr 12; 22(1):42. PubMed ID: 38610057
    [Abstract] [Full Text] [Related]

  • 29. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.
    Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T.
    J Pediatr; 2006 Aug 12; 149(2):237-40. PubMed ID: 16887442
    [Abstract] [Full Text] [Related]

  • 30. Therapeutic Window of Intravenous Immunoglobulin (IVIG) and its correlation with IVIG-resistant in Kawasaki Disease: a retrospective study.
    Cai JH, Tang M, Zhang HX, Dan Luo E, Zhang R, Shuai SP, Liang H, Tao WJ, Wu MJ, Wen Y, Yang YF.
    J Pediatr (Rio J); 2023 Aug 12; 99(2):161-167. PubMed ID: 35995125
    [Abstract] [Full Text] [Related]

  • 31. Development of an immunoinflammatory indicator-related dynamic nomogram based on machine learning for the prediction of intravenous immunoglobulin-resistant Kawasaki disease patients.
    Wang Y, Cao Y, Li Y, Zhu F, Yuan M, Xu J, Ma X, Li J.
    Int Immunopharmacol; 2024 Jun 15; 134():112194. PubMed ID: 38703570
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
    Lancet Child Adolesc Health; 2018 Dec 15; 2(12):855-862. PubMed ID: 30337183
    [Abstract] [Full Text] [Related]

  • 33. Verification of Current Risk Scores for Kawasaki Disease in Korean Children.
    Shin J, Lee H, Eun L.
    J Korean Med Sci; 2017 Dec 15; 32(12):1991-1996. PubMed ID: 29115081
    [Abstract] [Full Text] [Related]

  • 34. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.
    Han CL, Zhao SL.
    Med Sci Monit; 2018 Oct 11; 24():7264-7270. PubMed ID: 30307902
    [Abstract] [Full Text] [Related]

  • 35. The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease.
    Kawamura Y, Takeshita S, Kanai T, Yoshida Y, Nonoyama S.
    J Pediatr; 2016 Nov 11; 178():281-284.e1. PubMed ID: 27526622
    [Abstract] [Full Text] [Related]

  • 36. Immunoglobulin failure and retreatment in Kawasaki disease.
    Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C.
    Pediatr Cardiol; 2003 Nov 11; 24(2):145-8. PubMed ID: 12457253
    [Abstract] [Full Text] [Related]

  • 37. Do cytokines correlate with refractory Kawasaki disease in children?
    Wang Y, Qian SY, Yuan Y, Wang Q, Gao L, Chen X, Yu X, Zhen Z.
    Clin Chim Acta; 2020 Jul 11; 506():222-227. PubMed ID: 32156603
    [Abstract] [Full Text] [Related]

  • 38. The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study.
    Kanai T, Takeshita S, Kawamura Y, Kinoshita K, Nakatani K, Iwashima S, Takizawa Y, Hirono K, Mori K, Yoshida Y, Nonoyama S.
    Heart Vessels; 2020 Oct 11; 35(10):1463-1472. PubMed ID: 32449049
    [Abstract] [Full Text] [Related]

  • 39. Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST.
    Wang S, Huang H, Hou M, Xu Q, Qian W, Tang Y, Li X, Qian G, Ma J, Zheng Y, Shen Y, Lv H.
    Pediatr Res; 2023 Sep 11; 94(3):1125-1135. PubMed ID: 36964445
    [Abstract] [Full Text] [Related]

  • 40. Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different Ethnicities.
    Loomba RS, Raskin A, Gudausky TM, Kirkpatrick E.
    Am J Ther; 2016 Sep 11; 23(6):e1293-e1299. PubMed ID: 25611359
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.